Su Wan built the innovations that made her partners dream of a public listing, but they push her out just before the deal closes. Certain they can claim success without her, they overlook one fatal fact: the company depends on the three patents in her name. While their listing collapses under scrutiny and their valuation spirals downward, Su Wan launches a venture of her own. As her new team reaches the market first, the people who betrayed her are left pleading for the expertise they tried to discard.
